Published by Benjamin Chiou on 24th February 2026
(Sharecast News) - Danish pharma giant Novo Nordisk is to halve the US price of obesity drug Wegovy and slash the price of diabetes treatment Ozempic from next year as competition ramps up with rival drugmaker Eli Lilly.
URL: http://www.digitallook.com/dl/news/story/35719703/...